All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0469 | Anti-EXOSC2 (2334C3a) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2334C3a | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0470 | Anti-EXOSC2 (CBFYE-0285) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0285 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0471 | Anti-EXOSC2 (CBFYE-1396) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1396 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0472 | Anti-EXOSC2 (CBFYE-1397) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1397 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0473 | Anti-EXOSC2 (CBFYE-1398) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1398 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0474 | Anti-EXOSC2 (CBFYE-1399) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1399 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3722 | Anti-EXOSC2 (2334C3a) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2334C3a | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3723 | Anti-EXOSC2 (CBFYE-0285) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0285 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3724 | Anti-EXOSC2 (CBFYE-1396) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1396 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3725 | Anti-EXOSC2 (CBFYE-1397) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1397 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3726 | Anti-EXOSC2 (CBFYE-1398) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1398 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3727 | Anti-EXOSC2 (CBFYE-1399) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1399 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION